Journals / Abant Tıp Dergisi / 2013 / Cilt: 2 - Sayı: 2

Peripartum Cardiomyopathy

Peripartum Kardiyomiyopati

Pages
161–167
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review the recent data about the epidemiology, diagnosis and prognosis of the disease is discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Peripartum cardiomyopathy is a form of dilated cardiomyopathy with a high rate of mother and fetus mortality.
📊
Key Findings & Data:It is diagnosed in the last four months of the pregnancy and fifth month of the postpartum period.
💡
Conclusion & Impact:In this review the recent data about the epidemiology, diagnosis and prognosis of the disease is discussed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:kardiyak · peripartum · kardiyomiyopati

Abstract

Peripartum cardiomyopathy is a form of dilated cardiomyopathy with a high rate of mother and fetus mortality. It is diagnosed in the last four months of the pregnancy and fifth month of the postpartum period. Although the exact underlying cause is uncertain; infections, myocarditis, immunologic factors, prolactin stimulated oxidative stress are accused for it. In this review the recent data about the epidemiology, diagnosis and prognosis of the disease is discussed.

Özet

Peripartum kardiyomyopati PPKMP yüksek anne ve bebek mortalitesi ile seyredebilen bir dilate kardiyomiyopati formudur. Peripartum kardiyomyopati gebeliğin son 4 haftası ve postpartum 5. aylar arasında görülmektedir. Altta yatan kesin neden belli olmamakla beraber enfeksiyonlar, myokardit, immünolojik faktörler, prolaktinin neden olduğu oksidatif stres gibi birçok neden suçlanmaktadır. Bu derlemede hastalığın epidemiyolojisi, etyolojisi, tanısı, tedavisi ve prognozu hakkındaki güncel veriler tartışılmıştır.

🔖

Cite This Article

KOÇAK, Ü., İPEK, G., TOK, D. (2022). Peripartum Cardiomyopathy. Abant Tıp Dergisi, Cilt: 2 - Sayı: 2, 161–167. https://ajindex.com/articles/427226

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Demakis JG, Rahimtoola SH. Peripartum cardiomyopa- thy. Circulation 1971; 44: 964–8.
  2. Manolio TA, Baughman KL, Rodeheffer R, Pearson TA, Bristow JD, Michels VV, Abelmann WH, Harlan WR. Prev- alence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am J Cardiol 1992; 69: 1458–66.
  3. Witlin AG, Mabie WC, Sibai BM. Peripartum cardiomy- opathy: a longitudinal echocardiographic study. Am J Obstet Gynecol 1997;177:1129–32.
  4. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, Ansari A,Baughman KL. Peripartum cardio- myopathy: National Heart, Lung and Blood Institute and Office of Rare Diseases Workshop recommendations and reviews. JAMA 2000; 283: 1183–8.
  5. Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peri- partum cardiomiopathy at a single insitution. Mayo Proc 2005; 80: 1602–6.
  6. Modi KA, Illum S, Jariatul K, Caldito G, Reddy PC. Poor outcome of indigent patients with peripartum cardiomy- opathy in the United States, Am J Obstet Gynecol 2009;201: 171.e1–5 Hilfiker-Kleiner D, Sliwa K, Drexler H. Peripartum cardi- omyopathy: recent insights in its patophysiology. Trends Cardiovasc Med 2008; 18: 173–9.
  7. Ntusi NBA, Mayosi BM. Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int J Cardiol 2009;131:168–79.
  8. Bultmann BD, Klingel K, Nabauer M, Wallwiener D, Kandolf R. High prevalence of viral genomes and inflam- mation in peripartum cardiomyopathy. Am J Obstet Gy- necol 2005; 193: 363-5.
  9. Melvin KR, Richardson PJ, Olsen EG, Daly K, Jackson G. Peripartum cardiomyopathy due to myocarditis. N Engl J Med 1982; 307: 731–4.
  10. Sanderson JE, Olsen EGJ, Gatei D. Peripartum heart disease: an endomyocardial biopsy study. Br Heart J 1986; 56: 285–91
  11. Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP. Viral persistence in the myo- cardium is associated with progressive cardiac dysfunc- tion. Circulation 2005; 112:1965–70.
  12. Sliwa K, Forster O, Tibazarwa K, Libhaber E, Becker A, Yip A, Hilfiker-Kleiner D.Long-term outcome of Peripar tum cardiomyopathy in a population with high seroposi- tivity for human immunodeficiency virus. Int J Cardiol. 2011; 147: 202–8
  13. Warraich RS, Sliwa K, Damasceno A, Carraway R, Sundrom B, Arif G, Essop R, Ansari A, Fett J, Yacoub M. Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunglobu- lins in peripartum cardiomyopa